CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-31 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −1,506 | $13.58 | $20K | 517,562 |
| 2020-03-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,528 | 25,970 | ||
| 2020-03-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,528 | 25,970 | ||
| 2020-03-31 | Kennedy Joseph T General Counsel | Option exercise | +1,806 | 195,313 | ||
| 2020-03-31 | Kennedy Joseph T General Counsel | Option exercise | +1,806 | 197,119 | ||
| 2020-03-31 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −1,806 | 30,691 | ||
| 2020-03-31 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −1,806 | 30,691 | ||
| 2020-03-31 | THERO JOHN F President and CEO | Option exercise | +6,736 | 2,487,177 | ||
| 2020-03-31 | THERO JOHN F President and CEO | Option exercise | +6,736 | 2,493,913 | ||
| 2020-03-31 | THERO JOHN F President and CEO | Shares withheld for taxes | −5,302 | $13.58 | $72K | 2,488,611 |
| 2020-03-31 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −6,736 | 114,513 | ||
| 2020-03-31 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −6,736 | 114,513 | ||
| 2020-03-04 | THERO JOHN F President and CEO | Sale | −200,000 | $15.99 | $3.2M | 2,480,441 |
| 2020-03-02 | Berg Aaron CHIEF COMMERCIAL OFFICER | Grant or award · Restricted Stock Units | +49,000 | 49,000 | ||
| 2020-03-02 | Kalb Michael Wayne SVP and CFO | Grant or award · Restricted Stock Units | +49,000 | 49,000 | ||
| 2020-03-02 | Ketchum Steven B Chief Scientific Officer | Grant or award · Restricted Stock Units | +49,000 | 49,000 | ||
| 2020-03-02 | Kennedy Joseph T General Counsel | Grant or award · Restricted Stock Units | +49,000 | 49,000 | ||
| 2020-03-02 | THERO JOHN F President and CEO | Grant or award · Restricted Stock Units | +178,100 | 178,100 | ||
| 2020-02-28 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise | +1,528 | 188,883 | ||
| 2020-02-28 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise | +1,528 | 190,411 |
Page 54 of 67 · 1,339 trades